TCRX earnings: a positive outcome, +5.4%

On March 9, 2022, TScan Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +5.4% in the window around the event. It had already run -27.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.